Clinical trial
Alkalinization of Adrenalized Lidocaine in Extending Epidural Analgesia for Extremely Urgent Cesarean Section During Labor: a Randomized Controlled Trial.
NCT05313256 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alkalinization of Adrenalized Lidocaine in Extending Epidural Analgesia for Extremely Urgent Cesarean Section During Labor: a Randomized Controlled Trial.
- Lead sponsor
- University Hospital, Bordeaux
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- July 14, 2022
- Completion date
- July 8, 2024
- Enrollment
- 65 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.